These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3257141)

  • 21. Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.
    Jacobs JY; Livermore DM; Davy KW
    J Antimicrob Chemother; 1984 Sep; 14(3):221-9. PubMed ID: 6436226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical characterization of the POM-1 metallo-β-lactamase from Pseudomonas otitidis.
    Borgianni L; De Luca F; Thaller MC; Chong Y; Rossolini GM; Docquier JD
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1755-8. PubMed ID: 25512428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.
    Afzal-Shah M; Woodford N; Livermore DM
    Antimicrob Agents Chemother; 2001 Feb; 45(2):583-8. PubMed ID: 11158758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
    Bedenić B
    Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-lactamase of Lysobacter enzymogenes: induction, purification and characterization.
    von Tigerstrom RG; Boras GJ
    J Gen Microbiol; 1990 Mar; 136(3):521-7. PubMed ID: 2118167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OXA-type beta-lactamases.
    Naas T; Nordmann P
    Curr Pharm Des; 1999 Nov; 5(11):865-79. PubMed ID: 10539993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
    Poirel L; Marqué S; Héritier C; Segonds C; Chabanon G; Nordmann P
    Antimicrob Agents Chemother; 2005 Jan; 49(1):202-8. PubMed ID: 15616297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of beta-lactamase in Proteus vulgaris.
    Okonogi K; Kuno M; Higashide E
    J Gen Microbiol; 1986 Jan; 132(1):143-50. PubMed ID: 3519851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological studies of the regulation of beta-lactamase expression in Pseudomonas maltophilia.
    Rosta S; Mett H
    J Bacteriol; 1989 Jan; 171(1):483-7. PubMed ID: 2783690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
    Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N
    Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D beta-lactamase from Ralstonia pickettii.
    Girlich D; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4217-25. PubMed ID: 15504844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous hydrolytic features for OXA-48-like β-lactamases.
    Oueslati S; Nordmann P; Poirel L
    J Antimicrob Chemother; 2015 Apr; 70(4):1059-63. PubMed ID: 25583748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical characterization of the carbapenem-hydrolyzing beta-lactamase AsbM1 from Aeromonas sobria AER 14M: a member of a novel subgroup of metallo-beta-lactamases.
    Yang Y; Bush K
    FEMS Microbiol Lett; 1996 Apr; 137(2-3):193-200. PubMed ID: 8998985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
    Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
    J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.